{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:57:08Z","timestamp":1791521828023,"version":"4.3.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Medication prescribing in long-term care facilities (LTCFs) is characterized by widespread polypharmacy and frequent exposure to potentially clinically relevant drug-drug interactions (DDIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from the Italian Prescription Day in LTCFs 2024, a national multicenter point-prevalence study conducted in 82 LTCFs, were analyzed. Prescriptions were classified using the Anatomical Therapeutic Chemical system, and DDIs were identified using an international consensus list. Resident-level variables were assessed using validated tools, and associations with DDI burden were examined using univariate mixed-effects Poisson regression models. Facility-level organizational characteristics were described by center-level DDI burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analysis included 3174 residents (mean age 84.8\u2009years; 74.1% women), with a mean of 7.7 prescribed drugs. Drugs acting on the nervous system, alimentary tract and metabolism, and cardiovascular system were most frequently prescribed; furosemide, paracetamol, pantoprazole, quetiapine, and macrogol were the most commonly used active substances. Overall, 42.2% of residents were exposed to at least one potentially clinically relevant DDI, most commonly involving centrally acting drugs, cumulative anticholinergic burden, serotonergic combinations, and potassium-related interactions. Higher DDI burden was associated with greater pharmacological complexity, depression, sleep disorders, cardiopulmonary disease, and behavioral and psychological symptoms of dementia, whereas older age, severe cognitive impairment, malnutrition, and dysphagia were associated with fewer DDIs. Facility-level and staffing characteristics showed limited differentiation, with assisted living facilities under-represented at higher DDI burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Potentially clinically relevant DDIs are common in Italian LTCFs and are primarily associated with resident-level clinical complexity, highlighting targets for medication review and deprescribing to improve medication safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/gerona\/glag104","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:41:14Z","timestamp":1776253274000},"source":"Crossref","is-referenced-by-count":1,"title":["Polypharmacy and drug-drug interactions in long-term care facilities residents: findings from the Italian Prescription Day Project"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0073-3792","authenticated-orcid":false,"given":"Alba","family":"Malara","sequence":"first","affiliation":[{"name":"Societ\u00e0 Italiana di Gerontologia e Geriatria , Florence,","place":["Italy"]},{"name":"Fondazione ANASTE Humanitas , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zucchelli","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi di Brescia , Brescia,","place":["Italy"]},{"name":"Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-6997","authenticated-orcid":false,"given":"Caterina","family":"Trevisan","sequence":"additional","affiliation":[{"name":"Societ\u00e0 Italiana di Gerontologia e Geriatria , Florence,","place":["Italy"]},{"name":"Universit\u00e0 degli Studi di Ferrara , Ferrara,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Dario","family":"Testa","sequence":"additional","affiliation":[{"name":"Societ\u00e0 Italiana di Gerontologia e Geriatria , Florence,","place":["Italy"]},{"name":"Dipartimento di Medicina Sperimentale e Clinica, Universit\u00e0 degli Studi di Firenze , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Borselli","sequence":"additional","affiliation":[{"name":"Societ\u00e0 Italiana di Gerontologia e Geriatria , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Castaldo","sequence":"additional","affiliation":[{"name":"Societ\u00e0 Italiana di Gerontologia e Geriatria , Florence,","place":["Italy"]},{"name":"ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0261-9897","authenticated-orcid":false,"given":"Antonio","family":"Cherubini","sequence":"additional","affiliation":[{"name":"IRCCS INRCA , Ancona,","place":["Italy"]},{"name":"Universit\u00e0 Politecnica delle Marche , Ancona,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Antonelli Incalzi","sequence":"additional","affiliation":[{"name":"Societ\u00e0 Italiana di Gerontologia e Geriatria , Florence,","place":["Italy"]},{"name":"Universit\u00e0 Campus Bio-Medico di Roma , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Marengoni","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi di Brescia , Brescia,","place":["Italy"]},{"name":"Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Morandi","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi di Brescia , Brescia,","place":["Italy"]},{"name":"Azienda Speciale Cremona Solidale , Cremona,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Onder","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Cattolica del Sacro Cuore , Rome,","place":["Italy"]},{"name":"Fondazione Policlinico Gemelli IRCCS , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Leosco","sequence":"additional","affiliation":[{"name":"Societ\u00e0 Italiana di Gerontologia e Geriatria , Florence,","place":["Italy"]},{"name":"Dipartimento di Scienze Mediche Traslazioni, Universit\u00e0 degli Studi di Napoli Federico II , Naples,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ungar","sequence":"additional","affiliation":[{"name":"Societ\u00e0 Italiana di Gerontologia e Geriatria , Florence,","place":["Italy"]},{"name":"Dipartimento di Medicina Sperimentale e Clinica, Universit\u00e0 degli Studi di Firenze , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Prescription Day LTCFs Workgroup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"2026052707020640600_glag104-B1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12877-022-03279-x","article-title":"Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis","volume":"22","author":"Delara","year":"2022","journal-title":"BMC Geriatr"},{"key":"2026052707020640600_glag104-B2","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1111\/jgs.70175","article-title":"Prevalence and Duration of Potential Drug-Drug Interactions Among US Nursing Home Residents, 2018-2020","volume":"73","author":"Reich","year":"2025","journal-title":"J Am Geriatr Soc"},{"key":"2026052707020640600_glag104-B3","doi-asserted-by":"publisher","first-page":"e2517965","DOI":"10.1001\/jamanetworkopen.2025.17965","article-title":"Interventions to address potentially inappropriate prescribing for older primary care patients: a systematic review and meta-analysis","volume":"8","author":"Persaud","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026052707020640600_glag104-B4","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.3390\/ijerph19074313","article-title":"Drug-related problems and polypharmacy in nursing home residents: a cross-sectional study","volume":"19","author":"D\u00edez","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026052707020640600_glag104-B5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s12877-024-05296-4","article-title":"Polypharmacy and potentially inappropriate medications in older adults who use long-term care services: a cross-sectional study","volume":"24","author":"Hagiwara","year":"2024","journal-title":"BMC Geriatr"},{"key":"2026052707020640600_glag104-B6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40520-025-03183-5","article-title":"Polypharmacy appropriateness in Italian long-term care facilities: the Nationwide Prescription Day Point Survey","volume":"37","author":"Malara","year":"2025","journal-title":"Aging Clin Exp Res"},{"key":"2026052707020640600_glag104-B7","year":"2024"},{"key":"2026052707020640600_glag104-B8","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.jamda.2021.03.019","article-title":"An international consensus list of potentially clinically significant drug-drug interactions in older people","volume":"22","author":"Anrys","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"2026052707020640600_glag104-B9","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026052707020640600_glag104-B10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","article-title":"Impact of anticholinergics on the aging brain: a review and practical application","volume":"4","author":"Boustani","year":"2008","journal-title":"Aging Health"},{"key":"2026052707020640600_glag104-B11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/gerona\/glr233","article-title":"Polypharmacy in nursing homes in Europe: results from the SHELTER study","volume":"67","author":"Onder","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026052707020640600_glag104-B12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12603-010-0051-9","article-title":"Health care for older people in Italy: the ULISSE Project","volume":"14","author":"Lattanzio","year":"2010","journal-title":"J Nutr Health Aging"},{"key":"2026052707020640600_glag104-B13","doi-asserted-by":"publisher","first-page":"535.e1","DOI":"10.1016\/j.jamda.2015.03.003","article-title":"Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review","volume":"16","author":"Jokanovic","year":"2015","journal-title":"J Am Med Dir Assoc"},{"key":"2026052707020640600_glag104-B14","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2147\/CIA.S216705","article-title":"Medication regimen complexity in Australian residential aged care facilities","volume":"14","author":"Chen","year":"2019","journal-title":"Clin Interv Aging"},{"key":"2026052707020640600_glag104-B15","doi-asserted-by":"publisher","first-page":"1067.e1","DOI":"10.1016\/j.jamda.2016.08.019","article-title":"Polypharmacy and medication regimen complexity as risk factors for hospitalization among residents of long-term care facilities","volume":"17","author":"Lalic","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"2026052707020640600_glag104-B16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/ageing\/afz136","article-title":"Morbidity and mortality among older people admitted to nursing homes","volume":"49","author":"Reilev","year":"2019","journal-title":"Age Ageing"},{"key":"2026052707020640600_glag104-B17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s40520-022-02094-z","article-title":"Italian guidelines on management of persons with multimorbidity and polypharmacy","volume":"34","author":"Onder","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"2026052707020640600_glag104-B18","doi-asserted-by":"publisher","first-page":"4708259","DOI":"10.1155\/2022\/4708259","article-title":"Mortality in elderly patients taking furosemide: a prospective cohort study","volume":"2022","author":"Rodr\u00edguez-Molinero","year":"2022","journal-title":"Int J Hypertens"},{"key":"2026052707020640600_glag104-B19","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1532-5415.2009.02376.x","article-title":"Pharmacological management of persistent pain in older persons","volume":"57","author":"American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"2026052707020640600_glag104-B20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40266-018-0559-x","article-title":"Paracetamol in older people: towards evidence-based dosing?","volume":"35","author":"Mian","year":"2018","journal-title":"Drugs Aging"},{"key":"2026052707020640600_glag104-B21","doi-asserted-by":"publisher","first-page":"105722","DOI":"10.1016\/j.jamda.2025.105722","article-title":"Usage and costs of regular acetaminophen in Canadian long-term care facilities","volume":"26","author":"Kraut","year":"2025","journal-title":"J Am Med Dir Assoc"},{"key":"2026052707020640600_glag104-B22","doi-asserted-by":"publisher","first-page":"105393","DOI":"10.1016\/j.jamda.2024.105393","article-title":"Over- and underuse of proton pump inhibitors in nursing homes","volume":"26","author":"Wabe","year":"2025","journal-title":"J Am Med Dir Assoc"},{"key":"2026052707020640600_glag104-B23","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/bcp.14232","article-title":"Off-label use of quetiapine in nursing homes","volume":"86","author":"M\u00fcller","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"2026052707020640600_glag104-B24","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"2026052707020640600_glag104-B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12912-020-0398-z","article-title":"Management of constipation in long-term care hospitals","volume":"19","author":"Takaoka","year":"2020","journal-title":"BMC Nurs"},{"key":"2026052707020640600_glag104-B26","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/13607863.2021.1922601","article-title":"Improving the appropriateness of psychotropic prescribing for nursing home residents with dementia: an overview of reviews","volume":"26","author":"Wiggin","year":"2022","journal-title":"Aging Ment Health"},{"key":"2026052707020640600_glag104-B27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000022013","article-title":"Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly","volume":"44","author":"Weiner","year":"1998","journal-title":"Gerontology"},{"key":"2026052707020640600_glag104-B28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/gerona\/gln043","article-title":"Number and dosage of central nervous system medications on recurrent falls in community elders","volume":"64","author":"Hanlon","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026052707020640600_glag104-B29","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/gerona\/glz173","article-title":"Association between medications acting on the central nervous system and fall-related injuries in community-dwelling older adults","volume":"75","author":"Gray","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026052707020640600_glag104-B30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s41999-024-01025-7","article-title":"A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial","volume":"15","author":"Simal","year":"2024","journal-title":"Eur Geriatr Med"},{"key":"2026052707020640600_glag104-B31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s41999-020-00376-1","article-title":"Polypharmacy, benzodiazepines, and antidepressants, but not antipsychotics, are associated with increased falls risk in UK care home residents","volume":"11","author":"Izza","year":"2020","journal-title":"Eur Geriatr Med"},{"key":"2026052707020640600_glag104-B32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/gerona\/glv091","article-title":"Antipsychotic and benzodiazepine drug changes affect acute falls risk differently in the nursing home","volume":"71","author":"Berry","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026052707020640600_glag104-B33","doi-asserted-by":"publisher","first-page":"e2435535","DOI":"10.1001\/jamanetworkopen.2024.35535","article-title":"Injurious fall risk differences among older adults with first-line depression treatments","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026052707020640600_glag104-B34","doi-asserted-by":"publisher","first-page":"afaf074","DOI":"10.1093\/ageing\/afaf074","article-title":"Risk of adverse outcomes associated with mirtazapine compared with sertraline use among older people living in long-term care facilities","volume":"54","author":"Hughes","year":"2025","journal-title":"Age Ageing"},{"key":"2026052707020640600_glag104-B35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","article-title":"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review","volume":"15","author":"Salahudeen","year":"2015","journal-title":"BMC Geriatr"},{"key":"2026052707020640600_glag104-B36","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s40266-021-00901-2","article-title":"Prevalence of anticholinergic polypharmacy and associated outcomes among Medicare patients with overactive bladder","volume":"38","author":"Campbell","year":"2021","journal-title":"Drugs Aging"},{"key":"2026052707020640600_glag104-B37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13195-024-01530-8","article-title":"Impact of cumulative exposure to anticholinergic and sedative drugs on cognition in older adults","volume":"16","author":"Reallon","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"2026052707020640600_glag104-B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000546109","article-title":"Selective serotonin reuptake inhibitors and risk of serotonin syndrome as consequence of drug-drug interactions: analysis of the FAERS database","volume":"34","author":"Novella","year":"2025","journal-title":"Med Princ Pract"},{"key":"2026052707020640600_glag104-B39","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/archinternmed.2010.142","article-title":"Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system","volume":"170","author":"Antoniou","year":"2010","journal-title":"Arch Intern Med"},{"key":"2026052707020640600_glag104-B40","doi-asserted-by":"publisher","first-page":"CD008165","DOI":"10.1002\/14651858.CD008165.pub5","article-title":"Interventions to improve the appropriate use of polypharmacy for older people","volume":"10","author":"Cole","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2026052707020640600_glag104-B41","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1186\/s12877-024-05450-y","article-title":"Prevalence of potentially inappropriate medications according to STOPP-Frail criteria in nursing home residents, the SHELTER study","volume":"24","author":"Malek Makan","year":"2024","journal-title":"BMC Geriatr"},{"key":"2026052707020640600_glag104-B42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40266-024-01177-y","article-title":"Psychotropic polypharmacy in dementia: a retrospective analysis for people with neuropsychiatric symptoms referred to an Australian dementia support service","volume":"42","author":"Atee","year":"2025","journal-title":"Drugs Aging"},{"key":"2026052707020640600_glag104-B43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ageing\/afaa159","article-title":"Deprescribing in older people approaching end of life: STOPPFrail version 2","volume":"50","author":"Curtin","year":"2021","journal-title":"Age Ageing"}],"container-title":["The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/advance-article-pdf\/doi\/10.1093\/gerona\/glag104\/68111240\/glag104.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/81\/6\/glag104\/68111240\/glag104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/81\/6\/glag104\/68111240\/glag104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:02:13Z","timestamp":1779879733000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article\/doi\/10.1093\/gerona\/glag104\/8658820"}},"subtitle":[],"editor":[{"given":"Joyce","family":"Siette","sequence":"additional","affiliation":[{"name":"(Medical Sciences Section)"}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5,7]]}},"URL":"https:\/\/doi.org\/10.1093\/gerona\/glag104","relation":{},"ISSN":["1079-5006","1758-535X"],"issn-type":[{"value":"1079-5006","type":"print"},{"value":"1758-535X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,17]]},"article-number":"glag104"}}